Expert Highlights Key Topics of Discussion at the 15th Annual New York Lung Cancers Symposium
Mark G. Kris, MD, discusses 1 of the major topics of discussion from the 15th Annual New York Lung Cancers Symposium, among other areas of focus at the meeting.
Mark G. Kris, MD, medical oncologist, William and Joy Ruane Chair in Thoracic Oncology, Memorial Sloan Kettering Cancer Center, discusses 1 of the major topics of discussion from the 15th Annual New York Lung Cancers Symposium, among other areas of focus at the meeting.
One of the key messages at this year’s meeting is that coronavirus disease 2019 (COVID-19) is now another complication of lung cancer, says Kris. The discussions during this meeting will focus on some very important issues in lung cancer, and at this time, COVID-19 has become a threat for patients with lung cancer that needs to be addressed.
Kris says that all but 2 of his patients with lung cancer died from the cancer as opposed to COVID-19, so this demonstrates it is a threat to patients that needs to be managed. This is an important topic at this year’s meeting, among others that will address new therapeutic approaches and emerging technologies in the lung cancer space.
ctDNA Detection Tied to Tumor Burden, Recurrence in HR+ Early Breast Cancer
December 13th 2024A phase 2 trial showed ctDNA detection in HR-positive early breast cancer was linked to larger tumors, higher residual cancer burden, and increased recurrence after neoadjuvant endocrine therapy.
Read More
Postoperative Radiation Improves HRQOL Over Endocrine Therapy in Breast Cancer
December 13th 2024In the phase 3 EUROPA trial, exclusive postoperative radiation therapy led to better health-related quality of life and fewer treatment-related adverse events in older patients with stage I luminal-like breast cancer at 24 months.
Read More
